Mingfei Wu

机构：Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Chongqing Public Health Medical Center, Hangzhou Medical College, Chongqing Medical University

发表论文 60 篇 · 总被引 543 次 · h-index 14

代表论文

Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors (2024 · Advanced Science · 被引 36)
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy (2024 · Journal of Medicinal Chemistry · 被引 24)
Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer (2023 · Bioorganic Chemistry · 被引 23)
An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti‐Solid Tumor Immunity (2024 · Advanced Materials · 被引 20)
Comparative toxicity of polystyrene, polypropylene, and polyethylene nanoplastics on Artemia franciscana nauplii: a multidimensional assessment (2023 · Environmental Science Nano · 被引 20)
Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody (2024 · European Journal of Medicinal Chemistry · 被引 19)